Publications

Oxygen-Sensitive MRI: A Predictive Imaging Biomarker for Tumor Radiation Response?

Arai TJ, Yang DM, Campbell JW, Chiu T, Cheng X, Stojadinovic S, Peschke P, Mason RP, 2021 Mar Int J Radiat Oncol Biol Phys

Evaluating online filtering algorithms to enhance dynamic multispectral optoacoustic tomography.

O'Kelly D, Guo Y, Mason RP, 2020 Sep Photoacoustics 19 100184

Oxygen-enhanced optoacoustic tomography reveals the effectiveness of targeting heme and oxidative phosphorylation at normalizing tumor vascular oxygenation.

Ghosh P, Guo Y, Ashrafi A, Chen J, Dey S, Zhong S, Liu J, Campbell J, Konduri PC, Gerberich J, Garrosian M, Mason RP, Zhang L, Liu L, 2020 Jun Cancer Res.

Preclinical Applications of Multi-Platform Imaging in Animal Models of Cancer.

Serkova NJ, Glunde K, Haney CR, Farhoud M, DeLille A, Redente EF, Simberg D, Westerly DC, Griffin L, Mason RP, 2020 Dec Cancer Res

Examining correlations of oxygen sensitive MRI (BOLD/TOLD) with [18F]FMISO PET in rat prostate tumors.

Zhou H, Chiguru S, Hallac RR, Yang D, Hao G, Peschke P, Mason RP, 2019 Am J Nucl Med Mol Imaging 2 9 156-167

The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells.

Dey S, Kumari S, Kalainayakan SP, Campbell J, Ghosh P, Zhou H, FitzGerald KE, Li M, Mason RP, Zhang L, Liu L 2018 Jan Oncotarget 3 9 4090-4101

Tumor physiological changes during hypofractionated stereotactic body radiation therapy assessed using multi-parametric magnetic resonance imaging.

Zhou H, Zhang Z, Denney R, Williams JS, Gerberich J, Stojadinovic S, Saha D, Shelton JM, Mason RP 2017 Mar Oncotarget

A role for dynamic contrast-enhanced magnetic resonance imaging in predicting tumour radiation response.

Hallac RR, Zhou H, Pidikiti R, Song K, Solberg T, Kodibagkar VD, Peschke P, Mason RP 2016 May Br. J. Cancer 11 114 1206-11

Developing oxygen-enhanced magnetic resonance imaging as a prognostic biomarker of radiation response.

White DA, Zhang Z, Li L, Gerberich J, Stojadinovic S, Peschke P, Mason RP 2016 Jun Cancer Lett. 1 380 69-77

Dynamic oxygen challenge evaluated by NMR T1 and T2 * - insights into tumor oxygenation.

Zhao D, Pacheco-Torres J, Hallac RR, White D, Peschke P, Cerdán S, Mason RP 2015 Jun NMR Biomed

Evaluation of tumor ischemia in response to an indole-based vascular disrupting agent using BLI and (19)F MRI.

Zhou H, Hallac RR, Lopez R, Denney R, MacDonough MT, Li L, Liu L, Graves EE, Trawick ML, Pinney KG, Mason RP 2015 Am J Nucl Med Mol Imaging 2 5 143-53

Correlations of noninvasive BOLD and TOLD MRI with pO2 and relevance to tumor radiation response.

Hallac RR, Zhou H, Pidikiti R, Song K, Stojadinovic S, Zhao D, Solberg T, Peschke P, Mason RP 2013 Jun Magn Reson Med

Oxygenation in cervical cancer and normal uterine cervix assessed using blood oxygenation level-dependent (BOLD) MRI at 3T.

Hallac RR, Ding Y, Yuan Q, McColl RW, Lea J, Sims RD, Weatherall PT, Mason RP 2012 Dec NMR Biomed 12 25 1321-30

A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment.

Mason RP, Zhao D, Liu L, Trawick ML, Pinney KG 2011 Apr Integr Biol (Camb) 4 3 375-87

Imaging-Guided Evaluation of the Novel Small-Molecule Benzosuberene Tubulin-Binding Agent KGP265 as a Potential Therapeutic Agent for Cancer Treatment.

Guo Y, Wang H, Gerberich JL, Odutola SO, Charlton-Sevcik AK, Li M, Tanpure RP, Tidmore JK, Trawick ML, Pinney KG, Mason RP, Liu L, 2021 Sep Cancers (Basel) 19 13

A scalable open-source MATLAB toolbox for reconstruction and analysis of multispectral optoacoustic tomography data.

O'Kelly D, Campbell J, Gerberich JL, Karbasi P, Malladi V, Jamieson A, Wang L, Mason RP, 2021 Oct Sci Rep 1 11 19872

Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors.

Liu L, O'Kelly D, Schuetze R, Carlson G, Zhou H, Trawick ML, Pinney KG, Mason RP, 2021 Apr Molecules 9 26

Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia.

Winn BA, Devkota L, Kuch B, MacDonough MT, Strecker TE, Wang Y, Shi Z, Gerberich JL, Mondal D, Ramirez AJ, Hamel E, Chaplin DJ, Davis P, Mason RP, Trawick ML, Pinney KG, 2020 Mar J. Nat. Prod.

Ratiometric pH imaging using a 1,2-dioxetane chemiluminescence resonance energy transfer sensor in live animals.

Ryan LS, Gerberich J, Haris U, Nguyen D, Mason RP, Lippert AR, 2020 Aug ACS Sens

Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization.

Niu H, Strecker TE, Gerberich JL, Campbell JW, Saha D, Mondal D, Hamel E, Chaplin DJ, Mason RP, Trawick ML, Pinney KG, 2019 May J. Med. Chem.

Oxygen-sensitive MRI assessment of tumor response to hypoxic gas breathing challenge.

Yang DM, Arai TJ, Campbell JW, Gerberich JL, Zhou H, Mason RP, 2019 May NMR Biomed e4101

Translating preclinical MRI methods to clinical oncology.

Hormuth DA, Sorace AG, Virostko J, Abramson RG, Bhujwalla ZM, Enriquez-Navas P, Gillies R, Hazle JD, Mason RP, Quarles CC, Weis JA, Whisenant JG, Xu J, Yankeelov TE, 2019 Mar J Magn Reson Imaging

) MRI of orthotopic lung tumors.

Zhou H, Belzile O, Zhang Z, Wagner J, Ahn C, Richardson JA, Saha D, Brekken RA, Mason RP 2019 Jan Magn Reson Med

A Chemiluminescent Probe for HNO Quantification and Real-Time Monitoring in Living Cells.

An W, Ryan LS, Reeves AG, Bruemmer KJ, Mouhaffel L, Gerberich JL, Winters A, Mason RP, Lippert AR 2019 Jan Angew. Chem. Int. Ed. Engl. 5 58 1361-1365

Kinetics-Based Measurement of Hypoxia in Living Cells and Animals Using an Acetoxymethyl Ester Chemiluminescent Probe.

Ryan LS, Gerberich J, Cao J, An W, Jenkins BA, Mason RP, Lippert AR, 2019 Apr ACS Sens

Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents.

Maguire CJ, Chen Z, Mocharla VP, Sriram M, Strecker TE, Hamel E, Zhou H, Lopez R, Wang Y, Mason RP, Chaplin DJ, Trawick ML, Pinney KG 2018 Oct Medchemcomm 10 9 1649-1662

Energy transfer chemiluminescence for ratiometric pH imaging.

An W, Mason RP, Lippert AR 2018 May Org. Biomol. Chem.

Tomographic breathing detection: a method to noninvasively assess in situ respiratory dynamics.

O'Kelly D, Zhou H, Mason RP 2018 May J Biomed Opt 5 23 1-6

Targeting Phosphatidylserine with Calcium-Dependent Protein-Drug Conjugates for the Treatment of Cancer.

Li R, Chiguru S, Li L, Kim D, Velmurugan R, Kim D, Devanaboyina SC, Tian H, Schroit A, Mason RP, Ober RJ, Ward ES 2018 Jan Mol. Cancer Ther. 1 17 169-182

Noninvasive Anatomical and Functional Imaging of Orthotopic Glioblastoma Development and Therapy using Multispectral Optoacoustic Tomography.

Balasundaram G, Ding L, Li X, Attia ABE, Dean-Ben XL, Ho CJH, Chandrasekharan P, Tay HC, Lim HQ, Ong CB, Mason RP, Razansky D, Olivo M 2018 Aug Transl Oncol 5 11 1251-1258

MR-CBCT image-guided system for radiotherapy of orthotopic rat prostate tumors.

Chiu TD, Arai TJ, Campbell Iii J, Jiang SB, Mason RP, Stojadinovic S 2018 PLoS ONE 5 13 e0198065

Oxygenation Imaging by Nuclear Magnetic Resonance Methods.

Zhou H, Arias-Ramos N, López-Larrubia P, Mason RP, Cerdán S, Pacheco-Torres J 2018 Methods Mol. Biol. 1718 297-313

Incorporating Oxygen-Enhanced MRI into Multi-Parametric Assessment of Human Prostate Cancer.

Zhou H, Hallac RR, Yuan Q, Ding Y, Zhang Z, Xie XJ, Francis F, Roehrborn CG, Sims RD, Costa DN, Raj GV, Mason RP 2017 Aug Diagnostics (Basel) 3 7

Oxygen breathing challenge- the simplest theranostic.

Mason RP 2017 Theranostics 16 7 3873-3875

Inorganic phosphate-triggered release of anti-cancer arsenic trioxide from a self-delivery system: an in vitro and in vivo study.

Chen FY, Yi JW, Gu ZJ, Tang BB, Li JQ, Li L, Kulkarni P, Liu L, Mason RP, Tang Q 2016 Mar Nanoscale 11 8 6094-100

Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.

Devkota L, Lin CM, Strecker TE, Wang Y, Tidmore JK, Chen Z, Guddneppanavar R, Jelinek CJ, Lopez R, Liu L, Hamel E, Mason RP, Chaplin DJ, Trawick ML, Pinney KG 2016 Mar Bioorg. Med. Chem. 5 24 938-56

Tumor radio-sensitivity assessment by means of volume data and magnetic resonance indices measured on prostate tumor bearing rats.

Belfatto A, White DA, Mason RP, Zhang Z, Stojadinovic S, Baroni G, Cerveri P 2016 Mar Med Phys 3 43 1275

Effective Rat Lung Tumor Model for Stereotactic Body Radiation Therapy.

Zhang Z, Wodzak M, Belzile O, Zhou H, Sishc B, Yan H, Stojadinovic S, Mason RP, Brekken RA, Chopra R, Story MD, Timmerman R, Saha D 2016 Jun Radiat. Res. 6 185 616-22

Synthesis and Biological Evaluation of Benzocyclooctene-based and Indene-based Anticancer Agents that Function as Inhibitors of Tubulin Polymerization.

Herdman CA, Strecker TE, Tanpure RP, Chen Z, Winters A, Gerberich J, Liu L, Hamel E, Mason RP, Chaplin DJ, Trawick ML, Pinney KG 2016 Dec Medchemcomm 12 7 2418-2427

Carbon ion radiotherapy decreases the impact of tumor heterogeneity on radiation response in experimental prostate tumors.

Glowa C, Karger CP, Brons S, Zhao D, Mason RP, Huber PE, Debus J, Peschke P 2016 Aug Cancer Lett. 2 378 97-103

In Vivo Chemiluminescent Imaging Agents for Nitroreductase and Tissue Oxygenation.

Cao J, Campbell J, Liu L, Mason RP, Lippert AR 2016 Apr Anal. Chem.

Commentary on Photoacoustic Tomography.

Mason RP 2015 Sep J. Nucl. Med.

The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts.

Strecker TE, Odutola SO, Lopez R, Cooper MS, Tidmore JK, Charlton-Sevcik AK, Li L, MacDonough MT, Hadimani MB, Ghatak A, Liu L, Chaplin DJ, Mason RP, Pinney KG, Trawick ML 2015 Sep Cancer Lett.

Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization.

Herdman CA, Devkota L, Lin CM, Niu H, Strecker TE, Lopez R, Liu L, George CS, Tanpure RP, Hamel E, Chaplin DJ, Mason RP, Trawick ML, Pinney KG 2015 Oct Bioorg. Med. Chem.

Assessment of tumor response to oxygen challenge using quantitative diffusion MRI in an animal model.

Zhang Z, Yuan Q, Zhou H, Zhao D, Li L, Gerberich JL, Mason RP 2015 Nov J Magn Reson Imaging 5 42 spcone

Chemiluminescent Probes for Imaging H2S in Living Animals.

Cao J, Lopez R, Thacker JM, Moon JY, Jiang C, Morris SN, Bauer JH, Tao P, Mason RP, Lippert AR 2015 Mar Chem Sci 3 6 1979-1985

TH-CD-204-05: Developing a Non-Invasive MRI Prognostic Biomarker to Predict Response to Hypofractionated Radiotherapy.

White DA, Zhang Z, Li L, Gerberich J, Zhou H, Zhang Z, Saha D, Peschke P, Mason RP 2015 Jun Med Phys 6 42 3732

Mathematical modeling of tumor response to radiation: radio-sensitivity correlation with BOLD, TOLD, ?R1 and ?R2* investigated in large Dunning R3327-AT1 rat prostate tumors.

Belfatto A, White DA, Zhongwei ZhangZhang ZhangCerveri P, Baroni G, Mason RP 2015 Aug Conf Proc IEEE Eng Med Biol Soc 2015 3266-9

Assessment of tumor response to oxygen challenge using quantitative diffusion MRI in an animal model.

Zhang Z, Yuan Q, Zhou H, Zhao D, Li L, Gerberich JL, Mason RP 2015 Apr J Magn Reson Imaging

Convertible MRI contrast: Sensing the delivery and release of anti-glioma nano-drugs.

Zhang L, Zhang Z, Mason RP, Sarkaria JN, Zhao D 2015 Sci Rep 5 9874

Red-shifted emission from 1,2-dioxetane-based chemiluminescent reactions.

Park JY, Gunpat J, Liu L, Edwards B, Christie A, Xie XJ, Kricka LJ, Mason RP 2014 Sep Luminescence 6 29 ii

Dynamic bioluminescence and fluorescence imaging of the effects of the antivascular agent Combretastatin-A4P (CA4P) on brain tumor xenografts.

Liu L, Mason RP, Gimi B 2014 Oct Cancer Lett.

Use of Fc-Engineered Antibodies as Clearing Agents to Increase Contrast During PET.

Swiercz R, Chiguru S, Tahmasbi A, Ramezani SM, Hao G, Challa DK, Lewis MA, Kulkarni PV, Sun X, Ober RJ, Mason RP, Ward ES 2014 May J. Nucl. Med.

Phosphatidylserine-targeted molecular imaging of tumor vasculature by magnetic resonance imaging.

Zhou H, Stafford JH, Hallac RR, Zhang L, Huang G, Mason RP, Gao J, Thorpe PE, Zhao D 2014 May J Biomed Nanotechnol 5 10 846-55

Development of Intrinsically Photoluminescent and Photostable Polylactones.

Xie Z, Zhang Y, Liu L, Weng H, Mason RP, Tang L, Nguyen KT, Hsieh JT, Yang J 2014 Mar Adv. Mater. Weinheim

Dynamic contrast enhanced fluorescent molecular imaging of vascular disruption induced by combretastatin-A4P in tumor xenografts.

Liu L, Su X, Mason RP 2014 Aug J Biomed Nanotechnol 8 10 1545-51

Red-shifted emission from 1,2-dioxetane-based chemiluminescent reactions.

Park JY, Gunpat J, Liu L, Edwards B, Christie A, Xie XJ, Kricka LJ, Mason RP 2014 Apr Luminescence

Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent.

Hadimani MB, Macdonough MT, Ghatak A, Strecker TE, Lopez R, Sriram M, Nguyen BL, Hall JJ, Kessler RJ, Shirali AR, Liu L, Garner CM, Pettit GR, Hamel E, Chaplin DJ, Mason RP, Trawick ML, Pinney KG 2013 Sep J. Nat. Prod. 9 76 1668-78

GdDO3NI, a nitroimidazole-based T 1 MRI contrast agent for imaging tumor hypoxia in vivo.

Gulaka PK, Rojas-Quijano F, Kovacs Z, Mason RP, Sherry AD, Kodibagkar VD 2013 Nov J. Biol. Inorg. Chem.

Simultaneous measurement of tissue oxygen level-dependent (TOLD) and blood oxygenation level-dependent (BOLD) effects in abdominal tissue oxygenation level studies.

Ding Y, Mason RP, McColl RW, Yuan Q, Hallac RR, Sims RD, Weatherall PT 2013 Jun J Magn Reson Imaging

A noninvasive tumor oxygenation imaging strategy using magnetic resonance imaging of endogenous blood and tissue water.

Zhang Z, Hallac RR, Peschke P, Mason RP 2013 Feb Magn Reson Med

Novel S-Gal(®) analogs as (1)H MRI reporters for in vivo detection of ?-galactosidase.

Gulaka PK, Yu JX, Liu L, Mason RP, Kodibagkar VD 2013 Apr Magn Reson Imaging

New frontiers and developing applications in (19)F NMR.

Yu JX, Hallac RR, Chiguru S, Mason RP 2013 Apr Prog Nucl Magn Reson Spectrosc 70 25-49

Blood oxygenation level-dependent (BOLD) contrast magnetic resonance imaging (MRI) for prediction of breast cancer chemotherapy response: A pilot study.

Jiang L, Weatherall PT, McColl RW, Tripathy D, Mason RP 2012 Nov J Magn Reson Imaging

Novel Fe(3+)-Based (1)H MRI ?-Galactosidase Reporter Molecules**

Yu JX, Gulaka PK, Liu L, Kodibagkar VD, Mason RP 2012 May Chempluschem 5 77 370-378

Dual (19)F/(1)H MR Gene Reporter Molecules for in Vivo Detection of ?-Galactosidase.

Yu JX, Kodibagkar VD, Hallac RR, Liu L, Mason RP 2012 Mar Bioconjug. Chem. 3 23 596-603

6-Trifluoromethylpyridoxine: novel (19)F NMR pH indicator for in vivo detection.

Yu JX, Cui W, Bourke VA, Mason RP 2012 Aug J. Med. Chem. 15 55 6814-21

Comparison of optical and power Doppler ultrasound imaging for non-invasive evaluation of arsenic trioxide as a vascular disrupting agent in tumors.

Alhasan MK, Liu L, Lewis MA, Magnusson J, Mason RP 2012 PLoS ONE 9 7 e46106

Tubulin-destabilizing agent BPR0L075 induces vascular-disruption in human breast cancer mammary fat pad xenografts.

Liu L, Beck H, Wang X, Hsieh HP, Mason RP, Liu X 2012 PLoS ONE 8 7 e43314

Serial non-invasive monitoring of renal disease following immune-mediated injury using near-infrared optical imaging.

Du Y, An S, Liu L, Li L, Zhou XJ, Mason RP, Mohan C 2012 PLoS ONE 9 7 e43941

Uncoupling hypoxia signaling from oxygen sensing in the liver results in hypoketotic hypoglycemic death.

Kucejova B, Sunny NE, Nguyen AD, Hallac R, Fu X, Peña-Llopis S, Mason RP, Deberardinis RJ, Xie XJ, Debose-Boyd R, Kodibagkar VD, Burgess SC, Brugarolas J 2011 May Oncogene 18 30 2147-60

Hexamethyldisiloxane-based nanoprobes for (1) H MRI oximetry.

Gulaka PK, Rastogi U, McKay MA, Wang X, Mason RP, Kodibagkar VD 2011 Mar

Quantitative tissue oxygen measurement in multiple organs using (19) F MRI in a rat model.

Liu S, Shah SJ, Wilmes LJ, Feiner J, Kodibagkar VD, Wendland MF, Mason RP, Hylton N, Hopf HW, Rollins MD 2011 Jun

Upregulation of TRAG3 gene in urothelial carcinoma of the bladder.

Karam JA, Huang S, Fan J, Stanfield J, Schultz RA, Pong RC, Sun X, Mason RP, Xie XJ, Niu G, Chen X, Frenkel EP, Sagalowsky AI, Hsieh JT 2011 Jun Int. J. Cancer 12 128 2823-32

In vivo near-infrared spectroscopy and magnetic resonance imaging monitoring of tumor response to combretastatin A-4-phosphate correlated with therapeutic outcome.

Zhao D, Chang CH, Kim JG, Liu H, Mason RP 2011 Jun Int. J. Radiat. Oncol. Biol. Phys. 2 80 574-81

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model.

Saha D, Dunn H, Zhou H, Harada H, Hiraoka M, Mason RP, Zhao D 2011 J Vis Exp 56

Multimodality imaging of hypoxia in preclinical settings.

Mason RP, Zhao D, Pacheco-Torres J, Cui W, Kodibagkar VD, Gulaka PK, Hao G, Thorpe P, Hahn EW, Peschke P 2010 Jun Q J Nucl Med Mol Imaging 3 54 259-80

S-Gal, a novel 1H MRI reporter for beta-galactosidase.

Cui W, Liu L, Kodibagkar VD, Mason RP 2010 Jul Magn Reson Med 1 64 65-71

On the potential for molecular imaging with Cerenkov luminescence.

Lewis MA, Kodibagkar VD, Öz OK, Mason RP 2010 Dec Opt Lett 23 35 3889-91

Imaging beta-galactosidase activity in human tumor xenografts and transgenic mice using a chemiluminescent substrate.

Liu L, Mason RP 2010 PLoS ONE 8 5 e12024

Development of aliphatic biodegradable photoluminescent polymers.

Yang J, Zhang Y, Gautam S, Liu L, Dey J, Chen W, Mason RP, Serrano CA, Schug KA, Tang L 2009 Jun Proc. Natl. Acad. Sci. U.S.A. 25 106 10086-91

Comparison of 1H blood oxygen level-dependent (BOLD) and 19F MRI to investigate tumor oxygenation.

Zhao D, Jiang L, Hahn EW, Mason RP 2009 Aug Magn Reson Med 2 62 357-64

Dynamic near-infrared optical imaging of 2-deoxyglucose uptake by intracranial glioma of athymic mice.

Zhou H, Luby-Phelps K, Mickey BE, Habib AA, Mason RP, Zhao D 2009 PLoS ONE 11 4 e8051

High-throughput quantitative bioluminescence imaging for assessing tumor burden.

Contero A, Richer E, Gondim A, Mason RP 2009 Methods Mol. Biol. 574 37-45

Proton imaging of siloxanes to map tissue oxygenation levels (PISTOL): a tool for quantitative tissue oximetry.

Kodibagkar VD, Wang X, Pacheco-Torres J, Gulaka P, Mason RP 2008 Oct NMR Biomed 8 21 899-907

Pten haploinsufficiency accelerates formation of high-grade astrocytomas.

Kwon CH, Zhao D, Chen J, Alcantara S, Li Y, Burns DK, Mason RP, Lee EY, Wu H, Parada LF 2008 May Cancer Res. 9 68 3286-94

Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine.

Jennewein M, Lewis MA, Zhao D, Tsyganov E, Slavine N, He J, Watkins L, Kodibagkar VD, O'Kelly S, Kulkarni P, Antich PP, Hermanne A, Rösch F, Mason RP, Thorpe PE 2008 Mar Clin. Cancer Res. 5 14 1377-85

Exploring feasibility of multicolored CdTe quantum dots for in vitro and in vivo fluorescent imaging.

Su J, Zhang J, Liu L, Huang Y, Mason RP 2008 Mar J Nanosci Nanotechnol 3 8 1174-7

Evaluation of red CdTe and near infrared CdHgTe quantum dots by fluorescent imaging.

Zhang J, Su J, Liu L, Huang Y, Mason RP 2008 Mar J Nanosci Nanotechnol 3 8 1155-9

Molecular imaging of hypoxia.

Krohn KA, Link JM, Mason RP 2008 Jun J. Nucl. Med. 49 Suppl 2 129S-48S

Antivascular effects of combretastatin A4 phosphate in breast cancer xenograft assessed using dynamic bioluminescence imaging and confirmed by MRI.

Zhao D, Richer E, Antich PP, Mason RP 2008 Jul FASEB J. 7 22 2445-51

In vitro and In vivo Assessment of CdTe and CdHgTe Toxicity and Clearance.

Liu L, Zhang J, Su X, Mason RP 2008 Dec J Biomed Nanotechnol 4 4 524-528

A 19F-NMR approach using reporter molecule pairs to assess beta-galactosidase in human xenograft tumors in vivo.

Yu JX, Kodibagkar VD, Liu L, Mason RP 2008 Aug NMR Biomed 7 21 704-12

Physical principles of quantitative nuclear magnetic resonance oximetry.

Kodibagkar VD, Wang X, Mason RP 2008 Front. Biosci. 13 1371-84

Correlation of radiation response with tumor oxygenation in the Dunning prostate R3327-AT1 tumor.

Bourke VA, Zhao D, Gilio J, Chang CH, Jiang L, Hahn EW, Mason RP 2007 Mar Int. J. Radiat. Oncol. Biol. Phys. 4 67 1179-86

19F-NMR detection of lacZ gene expression via the enzymic hydrolysis of 2-fluoro-4-nitrophenyl beta-D-galactopyranoside in vivo in PC3 prostate tumor xenografts in the mouse.

Liu L, Kodibagkar VD, Yu JX, Mason RP 2007 Jul FASEB J. 9 21 2014-9

The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy.

Karam JA, Fan J, Stanfield J, Richer E, Benaim EA, Frenkel E, Antich P, Sagalowsky AI, Mason RP, Hsieh JT 2007 Apr Int. J. Cancer 8 120 1795-802

Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.

Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, Chapman JD, Eckelman WC, Fyles AW, Giaccia AJ, Hill RP, Koch CJ, Krishna MC, Krohn KA, Lewis JS, Mason RP, Melillo G, Padhani AR, Powis G, Rajendran JG, Reba R, Robinson SP, Semenza GL, Swartz HM, Vaupel P, Yang D, Croft B, Hoffman J, Liu G, Stone H, Sullivan D 2006 Oct Int. J. Radiat. Biol. 10 82 699-757

Tumor physiologic response to combretastatin A4 phosphate assessed by MRI.

Zhao D, Jiang L, Hahn EW, Mason RP 2005 Jul Int. J. Radiat. Oncol. Biol. Phys. 3 62 872-80

19F: a versatile reporter for non-invasive physiology and pharmacology using magnetic resonance.

Yu JX, Kodibagkar VD, Cui W, Mason RP 2005 Curr. Med. Chem. 7 12 819-48

Novel NMR platform for detecting gene transfection: synthesis and evaluation of fluorinated phenyl beta-D-galactosides with potential application for assessing LacZ gene expression.

Yu J, Otten P, Ma Z, Cui W, Liu L, Mason RP 2004 Nov-Dec Bioconjug. Chem. 6 15 1334-41

Comparison of BOLD contrast and Gd-DTPA dynamic contrast-enhanced imaging in rat prostate tumor.

Jiang L, Zhao D, Constantinescu A, Mason RP 2004 May Magn Reson Med 5 51 953-60

Novel NMR approach to assessing gene transfection: 4-fluoro-2-nitrophenyl-beta-D-galactopyranoside as a prototype reporter molecule for beta-galactosidase.

Cui W, Otten P, Li Y, Koeneman KS, Yu J, Mason RP 2004 Mar Magn Reson Med 3 51 616-20

Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden.

Paroo Z, Bollinger RA, Braasch DA, Richer E, Corey DR, Antich PP, Mason RP 2004 Apr Mol Imaging 2 3 117-24

Measuring changes in tumor oxygenation.

Zhao D, Jiang L, Mason RP 2004 Meth. Enzymol. 386 378-418

Near-infrared spectroscopy and imaging of tumor vascular oxygenation.

Liu H, Gu Y, Kim JG, Mason RP 2004 Meth. Enzymol. 386 349-78

Molecular imaging in prostate cancer.

Karam JA, Mason RP, Koeneman KS, Antich PP, Benaim EA, Hsieh JT 2003 Oct J. Cell. Biochem. 3 90 473-83

Correlation of tumor oxygen dynamics with radiation response of the dunning prostate R3327-HI tumor.

Zhao D, Constantinescu A, Chang CH, Hahn EW, Mason RP 2003 May Radiat. Res. 5 159 621-31

Dynamic response of breast tumor oxygenation to hyperoxic respiratory challenge monitored with three oxygen-sensitive parameters.

Gu Y, Bourke VA, Kim JG, Constantinescu A, Mason RP, Liu H 2003 Jun Appl Opt 16 42 2960-7

Tumor oxygen dynamics: correlation of in vivo MRI with histological findings.

Zhao D, Ran S, Constantinescu A, Hahn EW, Mason RP 2003 Jul-Aug Neoplasia 4 5 308-18

Interplay of tumor vascular oxygenation and tumor pO2 observed using near-infrared spectroscopy, an oxygen needle electrode, and 19F MR pO2 mapping.

Kim JG, Zhao D, Song Y, Constantinescu A, Mason RP, Liu H 2003 Jan J Biomed Opt 1 8 53-62

Tumor oxygen dynamics: comparison of 19F MR EPI and frequency domain NIR spectroscopy.

Song Y, Worden KL, Jiang X, Zhao D, Constantinescu A, Liu H, Mason RP 2003 Adv. Exp. Med. Biol. 530 225-36

Oxygenation in a human tumor xenograft: manipulation through respiratory challenge and antibody-directed infarction.

Mason RP, Constantinescu A, Ran S, Thorpe PE 2003 Adv. Exp. Med. Biol. 530 197-204

Tumor oximetry: comparison of 19F MR EPI and electrodes.

Mason RP, Hunjan S, Constantinescu A, Song Y, Zhao D, Hahn EW, Antich PP, Peschke P 2003 Adv. Exp. Med. Biol. 530 19-27

Differential oxygen dynamics in two diverse Dunning prostate R3327 rat tumor sublines (MAT-Lu and HI) with respect to growth and respiratory challenge.

Zhao D, Constantinescu A, Hahn EW, Mason RP 2002 Jul Int. J. Radiat. Oncol. Biol. Phys. 3 53 744-56

Dynamic breast tumor oximetry: the development of prognostic radiology.

Song Y, Constantinescu A, Mason RP 2002 Dec Technol. Cancer Res. Treat. 6 1 471-8

Quantitative assessment of tumor oxygen dynamics: molecular imaging for prognostic radiology.

Mason RP, Ran S, Thorpe PE 2002 J. Cell. Biochem. Suppl. 39 45-53

Non-Invasive Determination of Tumor Oxygen Tension and Local Variation with Growth

R. P. Mason, P. P. Antich, E. E. Babcock, A. Constantinescu, P. Peschke and E. W. Hahn 1994 Int. J. Radiat. Oncol. Bi 95-103